Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 10MCG/5ML (2M...DOSAGE - INJECTABLE;INJECTION - 10MCG/5ML (2MCG/ML)
USFDA APPLICATION NUMBER - 208614
DOSAGE - INJECTABLE;INJECTION - 4MCG/2ML (2MC...DOSAGE - INJECTABLE;INJECTION - 4MCG/2ML (2MCG/ML)
USFDA APPLICATION NUMBER - 208614
DOSAGE - CAPSULE;ORAL - 0.5MCG
USFDA APPLICATION NUMBER - 20862
DOSAGE - CAPSULE;ORAL - 1MCG
USFDA APPLICATION NUMBER - 20862
DOSAGE - CAPSULE;ORAL - 2.5MCG
USFDA APPLICATION NUMBER - 20862
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Empty Capsules
Coating Systems & Additives
Solubilizers
Topical
Thickeners and Stabilizers
Film Formers & Plasticizers
Fillers, Diluents & Binders
Coloring Agents
Surfactant & Foaming Agents
Emulsifying Agents
Controlled & Modified Release
Taste Masking
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Doxcercalciferol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxcercalciferol, including repackagers and relabelers. The FDA regulates Doxcercalciferol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxcercalciferol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxcercalciferol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxcercalciferol supplier is an individual or a company that provides Doxcercalciferol active pharmaceutical ingredient (API) or Doxcercalciferol finished formulations upon request. The Doxcercalciferol suppliers may include Doxcercalciferol API manufacturers, exporters, distributors and traders.
click here to find a list of Doxcercalciferol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxcercalciferol DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxcercalciferol active pharmaceutical ingredient (API) in detail. Different forms of Doxcercalciferol DMFs exist exist since differing nations have different regulations, such as Doxcercalciferol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Doxcercalciferol DMF submitted to regulatory agencies in the US is known as a USDMF. Doxcercalciferol USDMF includes data on Doxcercalciferol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxcercalciferol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Doxcercalciferol suppliers with USDMF on PharmaCompass.
A Doxcercalciferol written confirmation (Doxcercalciferol WC) is an official document issued by a regulatory agency to a Doxcercalciferol manufacturer, verifying that the manufacturing facility of a Doxcercalciferol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxcercalciferol APIs or Doxcercalciferol finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxcercalciferol WC (written confirmation) as part of the regulatory process.
click here to find a list of Doxcercalciferol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxcercalciferol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxcercalciferol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxcercalciferol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxcercalciferol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxcercalciferol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxcercalciferol suppliers with NDC on PharmaCompass.
Doxcercalciferol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxcercalciferol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxcercalciferol GMP manufacturer or Doxcercalciferol GMP API supplier for your needs.
A Doxcercalciferol CoA (Certificate of Analysis) is a formal document that attests to Doxcercalciferol's compliance with Doxcercalciferol specifications and serves as a tool for batch-level quality control.
Doxcercalciferol CoA mostly includes findings from lab analyses of a specific batch. For each Doxcercalciferol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxcercalciferol may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxcercalciferol EP), Doxcercalciferol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxcercalciferol USP).
LOOKING FOR A SUPPLIER?
